LONDON — Recent research indicates that cases of methicillin-resistant Staphylococcus aureus (MRSA) could be cut by as much as a third if high-risk areas are treated with a new cleaning product, according to Nursingtimes.net.
An 11-month study was conducted at Manchester Royal Infirmary and concludes that a new product, Byotrol, “could be a useful tool in the fight to get the problem under control after it was found to reduce MRSA levels by a third,” stated the article.
The study examined two general medical wards that used Byotrol, while two other wards were treated with cleaning bleach.
Lead researcher Dr. Andrew Dodgson, a consultant microbiologist, viewed the results as “very impressive,” reported the article.
Click here to read the complete article.
For related information, click here.